Sexton Biotechnologies, Inc. — Form D
Sexton Biotechnologies, Inc. of INDIANAPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2019-10-25. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-10-25
- Form: D
- Accession: 0001792289-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Minimum investment: $500K
- Investors: 4
- Date of first sale: 2019-10-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-351877
Issuer
- Name: Sexton Biotechnologies, Inc.
- CIK: 0001792289
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1102 INDIANA AVE., INDIANAPOLIS, IN, 46202
- Phone: (812) 339-2235
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Eli Casdin | Director | New York, NY |
| Doug Dayhoff | Director | Indianapolis, IN |
| Brad King | Director | Indianapolis, IN |
| Mike Rice | Director | Santa Fe, NM |
| Sean Werner | Director | Indianapolis, IN |
| Sean Werner | Executive Officer | Indianapolis, IN |
More